Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions
- 11 October 2018
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 152 (1), 202-207
- https://doi.org/10.1016/j.ygyno.2018.10.007
Abstract
No abstract availableKeywords
Funding Information
- Charles University in Prague (204024, Q28/LF1)
- Czech Research Council (16-31643A)
This publication has 24 references indexed in Scilit:
- ESGO Survey on Current Practice in the Management of Cervical CancerInternational Journal of Gynecologic Cancer, 2018
- Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2018
- Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancerGynecologic Oncology, 2017
- Cost‐effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early‐stage cervical cancerCancer, 2017
- Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 StudyAnnals of Surgical Oncology, 2016
- Sentinel lymph node biopsy in the management of gynecologic cancerCurrent Opinion in Obstetrics and Gynecology, 2015
- Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasisGynecologic Oncology, 2012
- Bilateral Negative Sentinel Nodes Accurately Predict Absence of Lymph Node Metastasis in Early Cervical Cancer: Results of the SENTICOL StudyJournal of Clinical Oncology, 2011
- Sentinel Node Dissection Is Safe in the Treatment of Early-Stage Vulvar CancerJournal of Clinical Oncology, 2008
- Sentinel lymph node biopsy improves staging in early cervical cancerGynecologic Oncology, 2007